Cargando…
In Vitro Cell Models for Ophthalmic Drug Development Applications
Tissue engineering is a rapidly expanding field that aims to establish feasible techniques to fabricate biologically equivalent replacements for diseased and damaged tissues/organs. Emerging from this prospect is the development of in vitro representations of organs for drug toxicity assessment. Due...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845647/ https://www.ncbi.nlm.nih.gov/pubmed/27158563 http://dx.doi.org/10.1089/biores.2016.0008 |
_version_ | 1782428982759653376 |
---|---|
author | Shafaie, Sara Hutter, Victoria Cook, Michael T. Brown, Marc B. Chau, David Y.S. |
author_facet | Shafaie, Sara Hutter, Victoria Cook, Michael T. Brown, Marc B. Chau, David Y.S. |
author_sort | Shafaie, Sara |
collection | PubMed |
description | Tissue engineering is a rapidly expanding field that aims to establish feasible techniques to fabricate biologically equivalent replacements for diseased and damaged tissues/organs. Emerging from this prospect is the development of in vitro representations of organs for drug toxicity assessment. Due to the ever-increasing interest in ocular drug delivery as a route for administration as well as the rise of new ophthalmic therapeutics, there is a demand for physiologically accurate in vitro models of the eye to assess drug delivery and safety of new ocular medicines. This review summarizes current existing ocular models and highlights the important factors and limitations that need to be considered during their use. |
format | Online Article Text |
id | pubmed-4845647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-48456472016-05-06 In Vitro Cell Models for Ophthalmic Drug Development Applications Shafaie, Sara Hutter, Victoria Cook, Michael T. Brown, Marc B. Chau, David Y.S. Biores Open Access Literature Review Tissue engineering is a rapidly expanding field that aims to establish feasible techniques to fabricate biologically equivalent replacements for diseased and damaged tissues/organs. Emerging from this prospect is the development of in vitro representations of organs for drug toxicity assessment. Due to the ever-increasing interest in ocular drug delivery as a route for administration as well as the rise of new ophthalmic therapeutics, there is a demand for physiologically accurate in vitro models of the eye to assess drug delivery and safety of new ocular medicines. This review summarizes current existing ocular models and highlights the important factors and limitations that need to be considered during their use. Mary Ann Liebert, Inc. 2016-04-01 /pmc/articles/PMC4845647/ /pubmed/27158563 http://dx.doi.org/10.1089/biores.2016.0008 Text en © Sara Shafaie et al. 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Literature Review Shafaie, Sara Hutter, Victoria Cook, Michael T. Brown, Marc B. Chau, David Y.S. In Vitro Cell Models for Ophthalmic Drug Development Applications |
title | In Vitro Cell Models for Ophthalmic Drug Development Applications |
title_full | In Vitro Cell Models for Ophthalmic Drug Development Applications |
title_fullStr | In Vitro Cell Models for Ophthalmic Drug Development Applications |
title_full_unstemmed | In Vitro Cell Models for Ophthalmic Drug Development Applications |
title_short | In Vitro Cell Models for Ophthalmic Drug Development Applications |
title_sort | in vitro cell models for ophthalmic drug development applications |
topic | Literature Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845647/ https://www.ncbi.nlm.nih.gov/pubmed/27158563 http://dx.doi.org/10.1089/biores.2016.0008 |
work_keys_str_mv | AT shafaiesara invitrocellmodelsforophthalmicdrugdevelopmentapplications AT huttervictoria invitrocellmodelsforophthalmicdrugdevelopmentapplications AT cookmichaelt invitrocellmodelsforophthalmicdrugdevelopmentapplications AT brownmarcb invitrocellmodelsforophthalmicdrugdevelopmentapplications AT chaudavidys invitrocellmodelsforophthalmicdrugdevelopmentapplications |